Holen Sie sich die Stockscreener-App
54.21
0.13%
0.07
Handel nachbörslich:
54.21
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Combining price and volume data for Tarsus Pharmaceuticals Inc.Market Risk Summary & Proven Capital Preservation Methods - Newser
Visualizing Tarsus Pharmaceuticals Inc. stock with heatmapsQuarterly Portfolio Summary & Growth-Oriented Investment Plans - Newser
Applying Elliott Wave Theory to Tarsus Pharmaceuticals Inc.July 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Evaluating Tarsus Pharmaceuticals Inc. with trendline analysisQuarterly Profit Review & Entry Point Confirmation Signals - Newser
Can machine learning forecast Tarsus Pharmaceuticals Inc. recoveryTrade Exit Summary & Reliable Intraday Trade Alerts - Newser
Top Risks to Consider Before Buying Tarsus Pharmaceuticals Inc. StockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
Why Tarsus Pharmaceuticals Inc. is moving todayPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - Newser
How Tarsus Pharmaceuticals Inc. stock performs during market volatilityInflation Watch & Verified Stock Trade Ideas - Newser
Volume spikes in Tarsus Pharmaceuticals Inc. stock – what they meanJuly 2025 Momentum & Verified Momentum Watchlists - Newser
Can technical indicators confirm Tarsus Pharmaceuticals Inc.’s reversal2025 Dividend Review & Safe Capital Investment Plans - Newser
Using Python tools to backtest Tarsus Pharmaceuticals Inc. strategies - Newser
Reversal indicators forming on Tarsus Pharmaceuticals Inc. stockQuarterly Trade Summary & Weekly Top Gainers Trade List - Newser
How to build a custom watchlist for Tarsus Pharmaceuticals Inc.Weekly Volume Report & AI Driven Price Predictions - Newser
How hedge fund analytics apply to Tarsus Pharmaceuticals Inc. stock2025 Analyst Calls & Fast Moving Market Watchlists - Newser
Tools to assess Tarsus Pharmaceuticals Inc.’s risk profileWeekly Stock Summary & Community Driven Trade Alerts - Newser
Tarsus Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMarket Trend Summary & High Accuracy Swing Trade Signals - Newser
Published on: 2025-08-14 04:24:26 - beatles.ru
Why Tarsus Pharmaceuticals Inc. stock attracts strong analyst attentionMarket Trend Summary & Accurate Trade Setup Notifications - Newser
Pattern recognition hints at Tarsus Pharmaceuticals Inc. upsideWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
Grading 2 Pharma Stocks That Are Heating Up as Large-Cap Rivals Falter - TheStreet Pro
Stocks To Watch: Tarsus Pharmaceuticals Sees RS Rating Jump To 87 - Investor's Business Daily
Tarsus Pharmaceuticals Q2 2025: Key Contradictions on XDEMVY's Market Potential, Discount Strategies, and Seasonal Sales Trends - AInvest
Published on: 2025-08-10 23:25:21 - Newser
Detecting support and resistance levels for Tarsus Pharmaceuticals Inc.Market Timing Strategy with Technical Filters - Newser
Tarsus Pharmaceuticals’ Earnings Call Highlights XDEMVY Success - TipRanks
Oppenheimer Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q2 2025 Earnings Call Transcript - Insider Monkey
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates - MSN
Tarsus Pharmaceuticals shares fall 7.01% after-hours following Q2 2025 earnings call. - AInvest
Tarsus Pharmaceuticals Reports Record Q2 Net Sales of $102.66M, Exceeding Consensus - AInvest
Guggenheim Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Maintains Target Price $84 - 富途牛牛
Tarsus Pharmaceuticals: Strong Sales Growth and Strategic Initiatives Drive Buy Rating - TipRanks
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by Envestnet Asset Management Inc. - Defense World
Tarsus targets 95,000–100,000 bottles for Q3 2025 amid accelerated XDEMVY launch momentum - MSN
Tarsus Pharmaceuticals: Scaling a High-Growth Eye Care Platform with a Diversified Pipeline and Strong Commercial Execution - AInvest
Tarsus Pharmaceuticals Sees 95,000-100,000 Bottles Target for Q3 2025 Amid Record-Breaking Sales - AInvest
Tarsus Pharmaceuticals Reports Record Sales Growth - TipRanks
Transcript : Tarsus Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Tarsus 2025 Q2 Earnings Loss Narrows as Revenue Surges 151.5% - AInvest
Tarsus Pharmaceuticals : Second Quarter 2025 Earnings Presentation - MarketScreener
Tarsus Pharmaceuticals Q2 revenue beats expectations - MarketScreener
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - The Globe and Mail
Tarsus Pharmaceuticals Reports Record $102.7 Million in Quarterly Net Product Sales of XDEMVY, a 152% Increase Year Over Year - Quiver Quantitative
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements - Yahoo Finance
Published on: 2025-08-04 16:33:09 - beatles.ru
How does Tarsus Pharmaceuticals Inc. compare to its industry peersProven strategies for superior portfolio growth - Jammu Links News
What are the technical indicators suggesting about Tarsus Pharmaceuticals Inc.Maximize gains with timely market signals - Jammu Links News
Is Tarsus Pharmaceuticals Inc. stock overvalued or undervaluedRapid growth opportunities - Jammu Links News
Why is Tarsus Pharmaceuticals Inc. stock attracting strong analyst attentionBuild wealth steadily with smart stock selection - Jammu Links News
Is Tarsus Pharmaceuticals Inc. a good long term investmentUnlock powerful stock screening for profits - Jammu Links News
Is it the right time to buy Tarsus Pharmaceuticals Inc. stockGet ahead with breakthrough trading ideas - Jammu Links News
When is Tarsus Pharmaceuticals Inc. stock expected to show significant growthAchieve rapid financial growth with smart picks - Jammu Links News
What is the dividend policy of Tarsus Pharmaceuticals Inc. stockUnlock your portfolio’s full growth potential - Jammu Links News
What are the latest earnings results for Tarsus Pharmaceuticals Inc.Phenomenal returns - Jammu Links News
What analysts say about Tarsus Pharmaceuticals Inc. stockBuild a portfolio that withstands market volatility - Jammu Links News
What institutional investors are buying Tarsus Pharmaceuticals Inc. stockInvest confidently with market-leading analysis - Jammu Links News
How strong is Tarsus Pharmaceuticals Inc. company’s balance sheetAchieve breakthrough financial results - Jammu Links News
What makes Tarsus Pharmaceuticals Inc. stock price move sharplyFree Stock Review Backed By Experts - jammulinksnews.com
Is Tarsus Pharmaceuticals Inc. a growth stock or a value stockChart Pattern Data Feed For Beginners - jammulinksnews.com
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):